Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era

BACKGROUND: Patients with stage II nasopharyngeal carcinoma were reported to benefit from adding cisplatin-based concurrent chemotherapy to two-dimensional conventional radiotherapy. But this benefit becomes uncertain in the intensity-modulated radiotherapy (IMRT) era, owing to its significant advan...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Zhang, Lu-Ning, Gao, Yuan-Hong, Lan, Xiao-Wen, Tang, Jie, Su, Zhen, Ma, Jun, Deng, Wuguo, OuYang, Pu-Yun, Xie, Fang-Yun
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2015
Sujets:
Clinical Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4791283/
https://ncbi.nlm.nih.gov/pubmed/26528755
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires